Etanercept found not optimal for reducing anterior uveitis in ankylosing spondylitisMarch 21, 2017Ankylosing spondylitisSpondyloarthropathies
Shingles vaccine deemed effective in people with autoimmune diseaseMarch 21, 2017Rheumatoid ArthritisAnkylosing spondylitisPsoriatic ArthritisSpondyloarthropathies
Biosimilars: No big dollar savings, but are clinically ‘dead on’March 7, 2017Rheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisAnkylosing spondylitisBusiness of Medicine
Perioperative infliximab does not increase serious infection riskFebruary 6, 2017Rheumatoid ArthritisOrthopedicsPsoriatic ArthritisSpondyloarthropathiesAnkylosing spondylitis
FDA opens abbreviated approval pathway for interchangeable biosimilarsJanuary 26, 2017SpondyloarthropathiesPsoriatic ArthritisRheumatoid ArthritisAnkylosing spondylitis
Reports of new-onset joint pain differ after starting vedolizumabJanuary 24, 2017SpondyloarthropathiesAnkylosing spondylitis
When primary anti-TNF fails in axial spondyloarthritis, consider comorbidities or second anti-TNFJanuary 13, 2017SpondyloarthropathiesAnkylosing spondylitis
Medicare payments set for infliximab biosimilar InflectraJanuary 10, 2017Rheumatoid ArthritisAnkylosing spondylitisPsoriatic ArthritisSpondyloarthropathies
VIDEO: Ankylosing spondylitis problems outside the joints strike more women than menDecember 6, 2016SpondyloarthropathiesAnkylosing spondylitis
VIDEO: Statins cut mortality in ankylosing spondylitis, psoriatic arthritisNovember 28, 2016Psoriatic ArthritisSpondyloarthropathiesAnkylosing spondylitis
Breast milk doesn’t contain meaningful levels of certolizumab pegolNovember 21, 2016Psoriatic ArthritisRheumatoid ArthritisSpondyloarthropathiesAnkylosing spondylitis
Infliximab biosimilar posts mostly reassuring data in Norway’s NOR-SWITCH studyNovember 20, 2016Rheumatoid ArthritisAnkylosing spondylitisPsoriatic ArthritisSpondyloarthropathies
What good are biosimilars if patients won’t use them?November 5, 2016Rheumatoid ArthritisAnkylosing spondylitisPsoriatic ArthritisSpondyloarthropathies
FDA’s Woodcock: Give biosimilars a chanceNovember 5, 2016Rheumatoid ArthritisPsoriatic ArthritisSpondyloarthropathiesPediatricsAnkylosing spondylitis
Biosimilars face barriers to broader acceptanceNovember 4, 2016Rheumatoid ArthritisPsoriatic ArthritisSpondyloarthropathiesAnkylosing spondylitisBusiness of Medicine
